Search Results - Levy, R.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. by McLaughlin, Peter (Author) , Grillo-López, A. J. (Author) , Link, B. K. (Author) , Levy, R. (Author) , Czuczman, M. S. (Author) , Williams, M. E. (Author) , Heyman, M. R. (Author) , Bence-Bruckler, I. (Author) , White, C. A. (Author) , Cabanillas, F. (Author) , Jain, V. (Author) , Ho, Anthony Dick (Author) , Lister, J. (Author) , Wey, K. (Author) , Shen, D. (Author) , Dallaire, B. K. (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext